Abstract
Aim
The aim of the present study is to explore whether atorvastatin improves intestinal inflammation through the inhibition of the TLR4/NFkB signaling pathway in TNBS-induced rat colitis.
Methods
Acute colitis was induced by intra-rectal administration of 100 mg/kg TNBS dissolved in 0.25 ml of 50 % ethanol. Twenty four hours after colitis induction, saline, atorvastatin (20 and 40 mg/kg) and sulfasalazine (100 mg/kg) were given to the animals by oral route. This was repeated daily for 1 week. Body weight changes, macroscopic and microscopic lesions were assessed. MPO and TNF-α activities were detected by immunohistochemistry (IHC) and the expression level of TLR4, MyD88 and NF-κB p65 proteins were measured by western blotting analysis.
Results
Atorvastatin and sulfasalazine reduced the body weight loss, macroscopic and microscopic lesions. Additionally, both drugs decreased the expression of MPO and TNF-α positive cells in the colon tissue. Furthermore, they inhibited the TNBS-induced expression of TLR4, MyD88 and NF-κB p65 proteins.
Conclusions
It is suggested that the anti-inflammatory effect of atorvastatin on TNBS-induced rat colitis may involve the inhibition of the TLR4/NFkB signaling pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aderem A (2001) Role of toll-like receptors in inflammatory response in macrophages. Crit Care Med 29:S16–S18
Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782–787
Aktunc E, Kayhan B, Arasli M, Gun BD, Barut F (2011) The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis. Immunopharmacol Immunotoxicol 33:667–675
Allred D, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol Off J US Can Acad Pathol Inc 11:155–168
Brubaker SW, Bonham KS, Zanoni I, Kagan JC (2015) Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol 33:257–290
Cario E (2010) Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 16:1583–1597
Deshmukh C, Veeresh B, Pawar A (2010) Protective effect of emblica officinalis fruit extract on acetic acid induced colitis in rats. J Herbal Med Toxicol 4:83–87
Dhamija P, Hota D, Kochhar R, Sachdev A, Chakrabarti A (2014) Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis. Indian J Gastroenterol 33:151–156
Didierlaurent A, Sirard JC, Kraehenbuhl JP, Neutra MR (2002) How the gut senses its content. Cell Microbiol 4:61–72
Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Ann Rev Immunol 20:197–216
Ke X et al (2013) Qing hua chang yin exerts therapeutic effects against ulcerative colitis through the inhibition of the tlr4/nf-κb pathway. Int J Mol Med 32:926–930
Khan I, Oriowo MA, Anim JT (2005) Amelioration of experimental colitis by na-h exchanger-1 inhibitor amiloride is associated with reversal of il-1β and erk mitogen-activated protein kinase. Scand J Gastroenterol 40:578–585
Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598–625
Kojouharoff G, Hans W, Obermeier F, Andus T, Gross V, Falk W (1997) Neutralization of tumour necrosis factor (tnf) but not of il-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107:353–358
Lee JY, Kim JS, Kim JM, Kim N, Jung HC, Song IS (2007) Simvastatin inhibits nf-κb signaling in intestinal epithelial cells and ameliorates acute murine colitis. Int Immunopharmacol 7:241–248
Li M-C, He S-H (2004) Il-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 10:620–625
Lin S et al (2012) Heme activates tlr4-mediated inflammatory injury via myd88/trif signaling pathway in intracerebral hemorrhage. J Neuroinflammation 9:46
Maron DJ, Fazio S, Linton MF (2000) Current perspectives on statins. Circulation 101:207–213
Molodecky NA et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(46–54):e42
Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803
Mukhopadhya A, Gilmour H, Plevris J (2008) Pravastatin-induced colitis. Eur J Gastroenterol Hepatol 20:810–812
Naito Y et al (2006) Rosuvastatin, a new hmg-coa reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. Int J Mol Med 17:997–1004
Ohkawara T et al (2006) Regulation of toll-like receptor 4 expression in mouse colon by macrophage migration inhibitory factor. Histochem Cell Biol 125:575–582
Pålsson-McDermott EM, O’Neill LA (2004) Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology 113:153–162
Rashidian A, Roohi P, Mehrzadi S, Ghannadi AR, Minaiyan M (2015) Protective effect of ocimum basilicum essential oil against acetic acid–induced colitis in rats. J Evid Based Complement Altern Med 2156587215616550
Rea W, Durrant D, Boldy D (2002) Ulcerative colitis after statin treatment. Postgrad Med J 78:286–287
Rutgeerts P (1999) Review article: efficacy of infliximab in crohn’s disease—induction and maintenance of remission. Aliment Pharmacol Ther 13:9–15
Sasaki M et al (2003) The 3-hydroxy-3-methylglutaryl-coa reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis. J Pharmacol Exp Ther 305:78–85
Scheiffele F,Fuss IJ (2002) Induction of tnbs colitis in mice Curr Protoc immunol 15.19. 11–15.19. 14
Szebeni B et al (2008) Increased expression of toll-like receptor (tlr) 2 and tlr4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol 151:34–41
Tan J, Pretorius CF, Flanagan PV, Pais A (2012) Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman. BMJ Case Reports 2012:bcr1120115270
Teng X, Xu L-F, Zhou P, Sun H-W, Sun M (2009) Effects of trefoil peptide 3 on expression of tnf-α, tlr4, and nf-κb in trinitrobenzene sulphonic acid induced colitis mice. Inflammation 32:120–129
Ungaro R et al (2009) A novel toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 296:G1167–G1179
Wang K, Wan YJY (2008) Nuclear receptors and inflammatory diseases. Exp Biol Med 233:496–506
Wierzbicki AS, Poston R, Ferro A (2003) The lipid and non-lipid effects of statins. Pharmacol Therap 99:95–112
Zeng Z, Zhan L, Liao H, Chen L, Lv X (2013) Curcumin improves tnbs-induced colitis in rats by inhibiting il-27 expression via the tlr4/nf-κb signaling pathway. Planta Med 79:102–109
Zhang S, Zhao X, Zhang D (2014) Cellular and molecular immunopathogenesis of ulcerative colitis. Cell Mol Immunol 11:314
Acknowledgments
This study is the partial completion of PhD thesis supported by Tehran University of Medical Sciences, Tehran, Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors state no conflict of interest.
Rights and permissions
About this article
Cite this article
Rashidian, A., Muhammadnejad, A., Dehpour, AR. et al. Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacol 24, 109–118 (2016). https://doi.org/10.1007/s10787-016-0263-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-016-0263-6